Bristly cell leukemia is a remarkable hematological threat portrayed by a gathering of unusual B lymphocytes. It is generally named a sub-sort of interminable lymphocytic leukemia (CLL). Shaggy cell leukemia makes up around 2% all things considered, with less than 2,000 new cases analyzed every year in North America and Western Europe consolidated. Bushy cell leukemia was initially portrayed as histiocytic leukemia, harmful reticulosis, or lymphoid myelofibrosis in distributions going back to the 1920s. The sickness was officially named leukemic reticuloendotheliosis and its portrayal essentially progressed by Bertha Bouroncle and partners at The Ohio State University College of Medicine in 1958. Its regular name, which was authored in 1966, is gotten from the "furry" appearance of the harmful B cells under a microscope.
Research Article: Journal of Cytology & Histology
Research Article: Journal of Cytology & Histology
Case Report: Journal of Cytology & Histology
Case Report: Journal of Cytology & Histology
Research Article: Journal of Cytology & Histology
Research Article: Journal of Cytology & Histology
Editorial: Journal of Cytology & Histology
Editorial: Journal of Cytology & Histology
Letter to Editor: Journal of Cytology & Histology
Letter to Editor: Journal of Cytology & Histology
Scientific Tracks Abstracts: Journal of Molecular Biomarkers & Diagnosis
Scientific Tracks Abstracts: Molecular Biomarkers & Diagnosis
Scientific Tracks Abstracts: Molecular and Genetic Medicine
Scientific Tracks Abstracts: Molecular and Genetic Medicine
Scientific Tracks Abstracts: Journal of Molecular Biomarkers & Diagnosis
Scientific Tracks Abstracts: Molecular Biomarkers & Diagnosis
Posters-Accepted Abstracts: Journal of Tissue Science and Engineering
Posters-Accepted Abstracts: Journal of Tissue Science and Engineering
Posters: Metabolomics:Open Access
Posters: Metabolomics:Open Access
Journal of Cytology & Histology received 2476 citations as per Google Scholar report